## Clinical Case: Pediatric Pulmonary TB — Diagnosis and Management ### Why Option 1 is Incorrect **Key Point:** Sputum smear microscopy has LOWER sensitivity in children, not higher. Pediatric TB is typically paucibacillary (low bacterial burden), making smear-positive cases rare in children. **Clinical Pearl:** This is a critical diagnostic trap. Children with TB often have: - Lower bacillary load in lesions (paucibacillary disease) - Difficulty producing sputum samples - Lower rates of smear positivity (5–10% in pediatric TB vs. 40–50% in adults) Diagnosis in children relies on: - Clinical and radiological findings - Tuberculin skin test (TST) / Mantoux test - Contact history with TB case - Culture and GeneXpert MTB/RIF (more sensitive than smear) ### Correct Statements Explained | Statement | Explanation | Clinical Relevance | |-----------|-------------|--------------------| | **Progressive primary TB** | Young children develop TB disease from recent infection; reactivation rare before adolescence | Reflects different pathophysiology in children vs. adults | | **DOT standard** | Directly observed therapy improves adherence, reduces resistance, ensures cure | Mandatory in TB-endemic areas; improves outcomes significantly | | **HRZE for 2 months** | Intensive phase: isoniazid, rifampicin, pyrazinamide, ethambutol × 2 months | Followed by HR × 4 months (total 6 months); ethambutol may be omitted in children <5 years | **High-Yield:** The **paucibacillary nature of pediatric TB** is why: - Smear microscopy is insensitive - Culture takes weeks to months - GeneXpert MTB/RIF is preferred rapid diagnostic - Contact tracing and clinical diagnosis are crucial **Mnemonic:** **P**ediatric TB = **P**aucibacillary (low bacilli) → **P**oor smear sensitivity → **P**refer culture/GeneXpert ### Treatment Regimen for This Child ```mermaid flowchart TD A[6-year-old with pulmonary TB]:::outcome --> B{Age and severity?}:::decision B -->|Age 6 years, non-severe| C[Intensive Phase: 2 months]:::action C --> D[HRZE: Isoniazid + Rifampicin + Pyrazinamide + Ethambutol]:::action D --> E[Continuation Phase: 4 months]:::action E --> F[HR: Isoniazid + Rifampicin]:::action F --> G[Total Duration: 6 months]:::outcome H[Note: Ethambutol may be omitted if age <5 or if no drug resistance suspected]:::decision ``` **Clinical Pearl:** In this 6-year-old, ethambutol CAN be used (age >5), but many pediatric programs still omit it due to difficulty monitoring optic neuritis. The question stem specifies HRZE, which is acceptable for this age.
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.